Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Ophthalmology and Therapy
Published in: Ophthalmology and Therapy 1/2017

Open Access 01-06-2017 | Case Report

Giant Cell Tumor of the Frontal Bone Presenting as an Orbital Mass

Authors: Peter H. Tang, Pradeep Mettu, Amanda C. Maltry, Andrew R. Harrison, Ali Mokhtarzadeh

Published in: Ophthalmology and Therapy | Issue 1/2017

Login to get access

Abstract

A 10-year-old male was referred for evaluation of a right orbital mass present for 3 weeks with associated tenderness to palpation. Magnetic resonance imaging (MRI) and computed tomography imaging (CT) revealed a solid mass centered in the frontal bone with extension into the orbit. Surgical excision and histologic analysis of the lesion was consistent with a diagnosis of a Giant Cell Tumor (GCT) of the frontal bone. The patient tolerated the procedure without complication and is doing well upon follow-up.
Literature
1.
Selva D, White VA, O’Connell JX, Rootman J. Primary bone tumors of the orbit. Surv Ophthalmol. 2004;49:328–42.CrossRefPubMed
2.
Herize M, Fein JM. Malignant giant cell tumor of the frontal bone. NY State J Med. 1984;84:201–2.
3.
Brien EW, Mirra JM, Kessler S, Suen M, Ho JK, Yang WT. Benign giant cell tumor of bone with osteosarcomatous transformation (“dedifferentiated” primary malignant GCT): report of two cases. Skeletal Radiol. 1997;26:246–55.CrossRefPubMed
4.
Dahlin DC, Cupps RE, Johnson-Jr EW. Giant-cell tumor: a study of 195 cases. Cancer. 1970;25:1061–70.CrossRefPubMed
5.
Ueno I, Toyoshima S, Fuchinoue T, Yahagi Y, Nakamura T, Kubo O. Primary giant cell tumor of the frontal bone with adjacent intracranial involvement. No Shinkei Geka. 1979;7:1101–8.PubMed
6.
Miyazaki Y, Takada I. Surgically treated case of a very rare giant cell tumor of the frontal bone. Geka Chiryo. 1970;22:112–6.PubMed
7.
Ferrington E, Mufson JA. Relationship of the so-called giant-cell tumor to the frontal bone; report of a case. Am J Clin Pathol. 1945;15:529–33.CrossRefPubMed
8.
Vinogradova TP. The international classification of bone tumors and some remarks concerning it. Arkh Patol. 1975;37:34–7.PubMed
9.
Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106–14.CrossRefPubMed
10.
Kashiwagi N, Hirabuki N, Andou K, Yoshifumi N, Tanaka H, Morino H, et al. MRI and CT findings of the giant cell tumors of the skull; five cases and a review of the literature. Eur J Radiol. 2006;58:435–43.CrossRefPubMed
11.
Tang JY, Wang CK, Su YC, Yang SF, Huang MY, Huang CJ. MRI appearance of giant cell tumor of the lateral skull base: a case report. Clin Imaging. 2003;27:27–30.CrossRefPubMed
12.
Chawla B, Khurana S, Kashyap S. Giant cell reparative granuloma of the orbit. Ophthal Plast Reconstr Surg. 2013;29:e94–5.CrossRefPubMed
13.
14.
Kamoshima Y, Sawamura Y, Imai T, Furukawa H, Kubota K, Houkin K. Giant cell tumor of the frontal bone in a girl: case report. Neurol Med Chir (Tokyo). 2011;51:798–800.CrossRefPubMed
15.
Ulu MO, Biceroglu H, Ozlen F, Oz B, Gazioglu N. Giant cell tumor of the frontal bone in an 18-month-old girl: a case report. Cent Eur Neurosurg. 2010;71:104–7.CrossRefPubMed
16.
Metadata
Title
Giant Cell Tumor of the Frontal Bone Presenting as an Orbital Mass
Authors
Peter H. Tang
Pradeep Mettu
Amanda C. Maltry
Andrew R. Harrison
Ali Mokhtarzadeh
Publication date
01-06-2017
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy / Issue 1/2017
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-017-0081-y

Other articles of this Issue 1/2017

Ophthalmology and Therapy 1/2017 Go to the issue

Review

A Review of Selective Laser Trabeculoplasty: Recent Findings and Current Perspectives

Erratum

Erratum to: A Review of Presbyopia Treatment with Corneal Inlays

Original Research

Screening for Diabetic Eye Disease among Samoan Adults: A Pilot Study

Original Research

Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy

Case Series

Cataract Surgery in Patients with a Previous History of KAMRA Inlay Implantation: A Case Series

Original Research

Resource Use and Real-World Outcomes for Ranibizumab Treat and Extend for Neovascular Age-Related Macular Degeneration in the UK: Interim Results from TERRA
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits